-
Long COVID affects millions of children. The largest pediatric trial so far launches this year.
One NIH study will test low-dose naltrexone, while other upcoming trials will test larozitide and taurine. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
Amazon Music
iHeartRadio
RSSTrending
Policy & Advocacy
-
HHS hosts event and announces new initiatives for Lyme disease, but advocates are skeptical about follow-through
-
“Medically neglected” and “structurally erased”: International network appeals for ME advocate Nevra Elis
-
Doctors who refuse to engage with administrative work are abandoning their poorest and sickest patients
-
Leslie Lee III, culture critic and Long COVID advocate, dies at 43
-
The future of Medicaid is “really scary” for people with Long COVID
-
“Not Recovered” protest for Long COVID, ME, and related diseases takes over The Hague
Science
-
Long COVID affects millions of children. The largest pediatric trial so far launches this year.
-
Research updates, February 3
-
Research updates, January 27
-
New RECOVER-TLC trials won’t enroll until summer. Nearly two years after the program’s launch.
-
Research updates, January 20
-
Severe people may hold answers to Long COVID. They must be included in research.
Covid-19
Health
-
Long COVID affects millions of children. The largest pediatric trial so far launches this year.
-
Metrodora promised comprehensive treatment. But within two years, it abruptly closed.
-
The CDC just sidelined these childhood vaccines. Here’s what they prevent.
-
Editor’s note: An update on a recent book excerpt
-
New AI tools are helping some people manage Long COVID
-
Telehealth is vital for people with Long COVID. Don’t let it disappear.
